Strategic Acquisition Kandu Health recently acquired Neurolutions, expanding its portfolio in neurorehabilitation devices, signaling a growth trajectory and potential cross-sell opportunities to its enhanced survivor care ecosystem.

Series B Momentum With a $30 million Series B led by Ally Bridge Group and AMED Ventures, Kandu Health demonstrates strong investor confidence and capital for scale, presenting opportunities to discuss enterprise deployments, data analytics partnerships, and expanded services.

Clinical Leadership Having a Chief Medical Officer and a CEO with stroke-focused leadership positions the company for clinical collaboration, clinical trial participation, and integration with hospital networks and stroke programs.

Digital Health Stack Utilizing Looker, Salesforce, Redshift, BigQuery, and other modern tools indicates readiness for data-driven population health solutions, enabling upsell of analytics, reporting, and care coordination platforms to health systems.

Imperative Alignment As a subsidiary of Imperative Care, Kandu Health can be positioned to align with hospital networks focused on stroke and vascular disease, offering integrated patient recovery pathways, device compatibility discussions, and bundled solutions.